Diabetes Medications (GLP-1 RAs) Show Promise in Reducing Colorectal Cancer Risk
*Title: Diabetes Medications Show Potential in Reducing Colorectal Cancer Risk, Study Finds* New York, December 8: A recent study suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a class of…










